Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$629M |
| 2 |
AGN
Allergan plc
AGN
|
+$463M |
| 3 |
State Street SPDR S&P Aerospace & Defense ETF
XAR
|
+$350M |
| 4 |
iShares Biotechnology ETF
IBB
|
+$315M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$265M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$978M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$675M |
| 3 |
Apple
AAPL
|
+$429M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$387M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$344M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.7% |
| 2 | Healthcare | 5.71% |
| 3 | Financials | 4.62% |
| 4 | Consumer Discretionary | 4.5% |
| 5 | Communication Services | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
Sunstone Hotel Investors
SHO
$2.06B
| $11M | 0.01% |
800,207
+170,002
| +27% | +$2.28M |
|
1227
CALL
Honeywell
HON
$78B
| $10.9M | 0.01% |
68,553
+12,626
| +23% | +$2.01M |
|
1228
PUT
Dow Inc
DOW
$21.2B
| $10.9M | 0.01% |
229,354
+88,930
| +63% | +$4.16M |
|
1229
PUT
BHP
BHP
$230B
| $10.9M | 0.01% |
248,031
-13,228
| -5% | -$618K |
|
1230
Acadia Pharmaceuticals
ACAD
$5.03B
| $10.9M | 0.01% |
303,278
+192,284
| +173% | +$5.83M |
|
1231
Burlington
BURL
$23.2B
| $10.9M | 0.01% |
54,579
+16,104
| +42% | +$2.96M |
|
1232
Zebra Technologies
ZBRA
$17.8B
| $10.8M | 0.01% |
52,422
+7,592
| +17% | +$1.53M |
|
1233
Invesco
IVZ
$13.9B
| $10.8M | 0.01% |
638,765
-145,184
| -19% | -$2.56M |
|
1234
CGI
GIB
$15.5B
| $10.8M | 0.01% |
136,525
-8,895
| -6% | -$694K |
|
|
LPT
1235
DELISTED
Liberty Property Trust
LPT
| $10.8M | 0.01% |
210,509
+8,836
| +4% | +$455K |
|
|
NSTG
1236
CALL
DELISTED
NanoString Technologies, Inc.
NSTG
| $10.8M | 0.01% |
500,000
+376,000
| +303% | +$9.98M |
|
1237
PUT
Regeneron Pharmaceuticals
REGN
$80.8B
| $10.8M | 0.01% |
38,900
-18,300
| -32% | -$5.42M |
|
1238
CALL
Occidental Petroleum
OXY
$55.9B
| $10.8M | 0.01% |
242,597
-538,003
| -69% | -$25.4M |
|
1239
Jazz Pharmaceuticals
JAZZ
$16.7B
| $10.7M | 0.01% |
83,755
+16,746
| +25% | +$2.24M |
|
|
AMRN
1240
Amarin Corp
AMRN
$303M
| $10.7M | 0.01% |
35,212
+5,680
| +19% | +$1.98M |
|
1241
Bright Horizons
BFAM
$3.86B
| $10.6M | 0.01% |
69,688
+50,437
| +262% | +$7.89M |
|
1242
MasTec
MTZ
$21.9B
| $10.6M | 0.01% |
163,599
-13,880
| -8% | -$810K |
|
1243
LPL Financial
LPLA
$28.6B
| $10.6M | 0.01% |
129,678
-149,762
| -54% | -$12M |
|
1244
PUT
MGM Resorts International
MGM
$11.2B
| $10.6M | 0.01% |
380,900
-220,400
| -37% | -$6.33M |
|
|
STOR
1245
DELISTED
STORE Capital Corporation
STOR
| $10.6M | 0.01% |
282,207
-42,370
| -13% | -$1.52M |
|
1246
United States Natural Gas Fund
UNG
$478M
| $10.6M | 0.01% |
132,351
-187,070
| -59% | -$15M |
|
|
WBA
1247
PUT
DELISTED
Walgreens Boots Alliance
WBA
| $10.5M | 0.01% |
190,200
-106,600
| -36% | -$5.71M |
|
1248
PUT
Cheniere Energy
LNG
$52.9B
| $10.5M | 0.01% |
166,800
-34,800
| -17% | -$2.23M |
|
|
JJG
1249
DELISTED
iPath Series B Bloomberg Grains Subindex Total ReturnSM ETN
JJG
| $10.5M | 0.01% |
236,000
-236,000
| -50% | -$10.5M |
|
|
CONE
1250
DELISTED
CyrusOne Inc Common Stock
CONE
| $10.5M | 0.01% |
132,566
-4,048
| -3% | -$270K |
|
Similar funds
Barclays's Q3 2019 Portfolio in Review
As of Q3 2019, Barclays held 7,551 positions worth $160B, down 2.1% from $163B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Barclays's Q3 2019 filing shows 501 new, 2,626 increased, 3,452 reduced and 568 closed positions. Its largest new stake was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $978M.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.5% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q3 2019 buy was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M.
- Barclays added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2019, an estimated $629M increase.
- Barclays's biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $978M.
- Barclays fully exited Anadarko Petroleum in Q3 2019, selling an estimated $309M.
- Barclays's ten largest holdings make up 28% of its $160B portfolio in Q3 2019.
- Barclays opened 501 new positions and closed 568 in Q3 2019.
- Barclays's portfolio value fell 2.1% quarter-over-quarter to $160B.
Based on Barclays's 13F filing for Q3 2019, filed 14 Nov 2019.